ADVANCED VIRAL RESEARCH CORP
POS AM, EX-23.1, 2000-10-20
PHARMACEUTICAL PREPARATIONS
Previous: ADVANCED VIRAL RESEARCH CORP, POS AM, 2000-10-20
Next: ADVANCED VIRAL RESEARCH CORP, POS AM, EX-27.1, 2000-10-20



<PAGE>   1
                                                                   EXHIBIT 23.1

               CONSENT OF INDEPENDENT CERTIFIED PUBLIC ACCOUNTANTS

         We hereby consent to the use in the Prospectus constituting part of
this Post-effective Amendment No. 1 to the Registration Statement on Form S-1 of
Advanced Viral Research Corp. of our report dated January 26, 2000 (except for
the fourth paragraph of Note 12, which is dated March 9, 2000) relating to the
consolidated financial statements of Advanced Viral Research Corp. as of
December 31, 1999 and 1998 and for each of the three years in the period ended
December 31, 1999 appearing in such Prospectus, which report contains an
explanatory paragraph that describes a condition that raises substantial doubt
as to the ability of Advanced Viral Research Corp. to continue as a going
concern. We also consent to the references to us under the heading "EXPERTS" in
the Prospectus.

                                                  /s/ RACHLIN COHEN & HOLTZ LLP
                                                     --------------------------
                                                      RACHLIN COHEN & HOLTZ LLP

Miami, Florida
October 17, 2000




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission